Marshall Wace, LLP Biocept Inc Transaction History

Marshall Wace, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.88 - $2.27 $81,672 - $210,678	-92,810 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.83 - $3.97 $116,060 - $251,781	-63,421 Reduced 40.59%	92,810 $215,000
Q4 2021 Feb 14, 2022	BUY	$3.43 - $4.22 $175,790 - $216,279	51,251 Added 48.82%	156,231 $566,000
Q3 2021 Nov 15, 2021	BUY	$3.39 - $4.34 $355,882 - $455,613	104,980 New	104,980 $421,000

Ticker BIOC
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,922,900
Market Cap $1.18M
Description
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.